Notable players in the ablation devices industry are :
Abbott Laboratories
Angiodynamics,
Atricure Inc.
Alcon Laboratories
Bausch & Lomb Incorporated
Biotronik SE & Co. KG
CONMED Corporation
Elekta AB.
Olympus Corporation
Varian
Ethicon
Inc (Johnson & Johnson)
Medtronic plc
Boston Scientific Corporation
Authors:
Mariam Faizullabhoy
Frequently Asked Questions (FAQ) :
Global market size for ablation devices was worth more than USD 8.6 billion in 2022 and is estimated to expand at over 9% CAGR between 2023 and 2032, given the remarkable growth in the burden of chronic diseases worldwide.
Radiofrequency devices segment is set to exhibit over 8.5% CAGR from 2023 to 2032, attributed to the widespread utilization of radiofrequency devices in a variety of healthcare applications, including oncology, cardiology, cosmetology, gynecology, and pain management.
Hospitals segment of the ablation devices market is primed to garner USD 11.3 billion in revenue by 2032, owing to the high incidence rate of ablation procedures taking place across these establishments.
Major companies in the ablation devices industry are Abbott Laboratories, AngioDynamics, Atricure Inc., Alcon Laboratories, Bausch & Lomb Incorporated, Biotronik SE & Co. KG, CONMED Corporation, Elekta AB., Olympus Corporation, Varian, Ethicon, Inc (Johnson & Johnson), Medtronic plc, Boston Scientific Corporation, and others.